title: Dramatic response to single-agent rituximab in a patient with intravascular lymphoma.
authors.forename: Nandagopal
authors.initials: N
authors.lastname: Vrindavanam
authors.forename: Mehdi
authors.initials: M
authors.lastname: Hamadani
authors.forename: Barbara
authors.initials: B
authors.lastname: Steele
authors.forename: Farrukh
authors.initials: F
authors.lastname: Awan
authors.forename: Saul
authors.initials: S
authors.lastname: Suster
authors.forename: Don M
authors.initials: DM
authors.lastname: Benson
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001808:Blood Vessels / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab